Compare ITSEC Asia Tbk. (CYBR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ITSEC Asia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? ITSEC Asia Tbk. trades at Rp560 (market cap 7.75T, 25.12M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: ITSEC Asia Tbk. is far larger — about 47.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and ITSEC Asia Tbk. is more actively traded (25.12M versus 62.5K). Which is the better fit depends on your goals.
| CYBR | OBAT | |
|---|---|---|
Market Cap | 7.75T | 164.65B |
Volume | 25.12M | 62.5K |
Lot | 251.2K | 625 |
Turnover | 14.16B | 15.03M |
Average Price | 563.65 | 240.55 |
Value | 14.16B | 15.03M |
Indicative Equilibrium Price | 560 | 238 |
Indicative Equilibrium Volume | 1.5K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ITSEC Asia Tbk.
PT ITSEC Asia Tbk (the “Company”) was established based on Notarial Deed No. 7 dated April 12, 2010 of Refizal, S.H., M.Hum., notary in Jakarta. The Company started its commercial operations in 2010.
Read more on CYBR →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
